Pareek A, Kumar D, Pareek A, Gupta M
Cancers (Basel). 2025; 17(5).
PMID: 40075725
PMC: 11898779.
DOI: 10.3390/cancers17050878.
Thanjavur N, Bugude L, Kim Y
Biosensors (Basel). 2025; 15(1).
PMID: 39852089
PMC: 11763654.
DOI: 10.3390/bios15010038.
Ren Y, Yang H, Xu D, Zhang Z, Gao S, Yu R
Int J Nanomedicine. 2025; 20():625-638.
PMID: 39839457
PMC: 11748046.
DOI: 10.2147/IJN.S493565.
Wang X, Zhu L, Gu Z, Dai L
Nanophotonics. 2024; 11(22):4955-4976.
PMID: 39634304
PMC: 11501915.
DOI: 10.1515/nanoph-2022-0574.
Starcea I, Lupu A, Nistor A, Mocanu M, Bogos R, Azoicai A
Front Mol Neurosci. 2024; 17:1391092.
PMID: 39318422
PMC: 11420925.
DOI: 10.3389/fnmol.2024.1391092.
Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements.
Nayak U, Halagali P, Panchal K, Panchal K, Tippavajhala V, Tippavajhala V
Curr Pharm Des. 2024; 31(6):443-460.
PMID: 39318210
DOI: 10.2174/0113816128328722240828184410.
Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer.
Oliveira Santos M, Teles-Souza J, de Araujo-Calumby R, Copeland Jr R, Marcelino H, Vilas-Boas D
Discov Nano. 2024; 19(1):142.
PMID: 39240502
PMC: 11379842.
DOI: 10.1186/s11671-024-04070-0.
Gold nanorod-based smart platform for efficient cellular uptake and combination therapy.
Kim K, Chejara M, Yoon B, Park M
RSC Adv. 2024; 14(37):27385-27393.
PMID: 39205927
PMC: 11350633.
DOI: 10.1039/d4ra06051b.
Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine.
Egwu C, Aloke C, Onwe K, Umoke C, Nwafor J, Eyo R
Molecules. 2024; 29(11).
PMID: 38893460
PMC: 11173789.
DOI: 10.3390/molecules29112584.
Nanotechnology's Applications and Potential in Various Fields.
Soni A, Jha R
Cureus. 2024; 16(4):e59234.
PMID: 38813303
PMC: 11134515.
DOI: 10.7759/cureus.59234.
Cytotoxicity of Quantum Dots in Receptor-Mediated Endocytic and Pinocytic Pathways in Yeast.
Okafor O, Kim K
Int J Mol Sci. 2024; 25(9).
PMID: 38731933
PMC: 11083673.
DOI: 10.3390/ijms25094714.
First-principles calculations on monolayer WX (X = S, Se) as an effective drug delivery carrier for anti-tuberculosis drugs.
Mahmud K, Yashir T, Zubair A
Nanoscale Adv. 2024; 6(9):2447-2458.
PMID: 38694461
PMC: 11059492.
DOI: 10.1039/d3na01095c.
CdSe/ZnS Quantum Dots' Impact on In Vitro Actin Dynamics.
Chand A, Le N, Kim K
Int J Mol Sci. 2024; 25(8).
PMID: 38673765
PMC: 11050122.
DOI: 10.3390/ijms25084179.
Recent advances of nanoparticles on bone tissue engineering and bone cells.
Zhang G, Zhen C, Yang J, Wang J, Wang S, Fang Y
Nanoscale Adv. 2024; 6(8):1957-1973.
PMID: 38633036
PMC: 11019495.
DOI: 10.1039/d3na00851g.
Oxidative stress-induced neurotoxicity of quantum dots and influencing factors.
Fang Q, Tang M
Nanomedicine (Lond). 2024; 19(11):1013-1028.
PMID: 38606672
PMC: 11225328.
DOI: 10.2217/nnm-2023-0326.
Applications of Quantum Dots in Preventive Oncology.
Sarkar S, Srivastava T, Sahoo O, Shankar A, Rai A, Pethusamy K
Asian Pac J Cancer Prev. 2024; 25(3):747-756.
PMID: 38546057
PMC: 11152399.
DOI: 10.31557/APJCP.2024.25.3.747.
Recent Developments in Nanotechnology and Immunotherapy for the Diagnosis and Treatment of Pancreatic Cancer.
Sindhi K, Kanugo A
Curr Pharm Biotechnol. 2024; 26(2):143-168.
PMID: 38415488
DOI: 10.2174/0113892010284407240212110745.
Quantum Dot Imaging Agents: Haematopoietic Cell Interactions and Biocompatibility.
Naylor-Adamson L, Price T, Booth Z, Stasiuk G, Calaminus S
Cells. 2024; 13(4.
PMID: 38391967
PMC: 10887166.
DOI: 10.3390/cells13040354.
Antibacterial Activity and Cytotoxicity Screening of Acyldepsipeptide-1 Analogues Conjugated to Silver/Indium/Sulphide Quantum Dots.
Cobongela S, Makatini M, May B, Njengele-Tetyana Z, Bambo M, Sibuyi N
Antibiotics (Basel). 2024; 13(2).
PMID: 38391569
PMC: 10886425.
DOI: 10.3390/antibiotics13020183.
Applications of Bioengineered Polymer in the Field of Nano-Based Drug Delivery.
Mishra S, Shah H, Patel A, Tripathi S, Malviya R, Prajapati B
ACS Omega. 2024; 9(1):81-96.
PMID: 38222544
PMC: 10785663.
DOI: 10.1021/acsomega.3c07356.